ArticleLa Radiologia medica2026
Ethanol ablation of cystic thyroid nodules: institutional experience with one year follow-up.
Article in La Radiologia medica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWe aimed to identify the main factors influencing the achievement of high efficacy or negative outcomes for ethanol ablation (EA) of cystic thyroid nodules.
methodsWe conducted a retrospective cohort study on consecutive patients treated with EA for cytologically benign and symptomatic CTNs at the Vanvitelli University Hospital in Naples (Italy) over a period of four years. Data was analyzed using multivariable logistic regression and Fisher's exact test. All tests were performed at the significant level of 0.05.
resultsWe included 118 nodules undergoing EA with one year follow-up [median volume 16.2 (7.0-32.8) mL], with important cervical symptomatology [overall visual analogue scale (VAS) score 26.0 (22.0-30.0) and cosmetic score (CS) 4.0 (3.0-4.0)]. At 12 months follow-up (T12), median VRR was 88.9 (77.2-97.6) %, overall VAS score and CS were 0 (0.0-1.5) and 1.0 (1.0-1.0), respectively. The classical EA was the only predictor of VRR > 75% (OR = 3.27; 95% CI 1.01-10.57; p = 0.048). Monolocular aspect was the only predictor (OR = 5.719; 95% CI 1.664-19.652; p = 0.006) of VAS = 0 and CS = 1.
conclusionsEA for CTNs is usually associated with high efficacy and rarely (one out of ten patients) with negative outcomes at one-year follow-up. The classical EA procedure (when the cystic content can be initially aspirated) and the monolocular aspect thyroid nodules seem to be factors that positively influence the high efficacy of EA, regardless of baseline nodule volume, ultrasound composition, number of EA sessions, and total ethanol amount.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.